Dr. Michael Soldan holds a PhD in Human Biology/Pharmacology from University Marburg. After one year as postdoctoral research fellow at University Marburg he worked for three years as Regulatory Affairs Manager at Centeon GmbH (now Aventis Behring GmbH). In 2001 he became Head of Regulatory Affairs Group at Hemophilia Europe. From 2003 to 2005 he was Head of Regulatory Affairs at Chiron Behring GmbH (now Novartis Behring). In 2005 he changed to Gruenenthal GmbH where he was Head of Corporate Regulatory Affairs. He held the same position at Biotest AG from 2006-2008 until he became Senior Vice President of the Medical/Regulatory Affairs Business Unit. As of July 2012 Dr. Soldan became Head Regulatory Global Department Biosimilars at Boehringer Ingelheim. He works now at Merck Serono.